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Background: Post-stroke cognitive impairment (PSCI) lessens quality of life, restricts the rehabilitation of stroke, and
increases the social and economic burden stroke imposes on patients and their families. Therefore effective
treatment is of paramount importance. However, the treatment of PSCI is very limited. The primary aim of this
protocol is to propose a lower cost and more effective therapy, and to confirm the long-term effectiveness of a
therapeutic regimen of Traditional Chinese Medicine (TCM) rehabilitation for PSCI.
Methods/Design: A prospective, multicenter, large sample, randomized controlled trial will be conducted. A total
of 416 eligible patients will be recruited from seven inpatient and outpatient stroke rehabilitation units and
randomly allocated into a therapeutic regimen of TCM rehabilitation group or cognitive training (CT) control
group. The intervention period of both groups will last 12 weeks (30 minutes per day, five days per week).
Primary and secondary outcomes will be measured at baseline, 12 weeks (at the end of the intervention), and 36
weeks (after the 24-week follow-up period).
Discussion: This protocol presents an objective design of a multicenter, large sample, randomized controlled trial
that aims to put forward a lower cost and more effective therapy, and confirm the long-term effectiveness of a
therapeutic regimen of TCM rehabilitation for PSCI through subjective and objective assessments, as well as
highlight its economic advantages.
Trial registration: This trial was registered with the Chinese Clinical Trial Registry (identifier: ChiCTR-TRC-14004872) on
23 June 2014.
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Cognitive impairment is considered as one of the major
long-term effects after a stroke [1, 2]. In China, post-
stroke cognitive impairment (PSCI) occurs in 55.9 % of
all patients who suffer a stroke [3]. In the United States,* Correspondence: lidianchen87@163.com
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creativecommons.org/publicdomain/zero/1.0/the total annual costs of stroke are thought to increase
to US$240.67 billion by 2030, and a large part of these
costs is caused by cognitive impairment [4]. In addition
to the direct effect on the quality of life of patients and
their families [5], there are also indirect effects of this
cognitive dysfunction on functional recovery, due to the
inability to actively participate in functional training and
the failure to follow task instructions [6]. Cognitive
impairment can influence patients’ self-confidence and
may cause depression, anxiety, and unwillingness to take
part in daily activities [7]. The presence of cognitiverticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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ery and has been associated with the risk of recurrent
stroke [8]. Therefore, interventions for PSCI are of para-
mount importance. Unfortunately, the effective interven-
tions of PSCI are very limited [9]. There are some
effective drug therapies, such as cholinesterase inhibitors
(for example donepezil [10]), cerebral circulation im-
provement agents, antidepressants, and other investiga-
tional drugs; however they have unavoidable side effects,
such as anorexia, nausea, vomiting, diarrhea, fatigue,
and vertigo [11]. New therapies, such as music therapy
[12] and hyperbaric oxygen therapy, have few evidence-
based medical studies and more research is needed to
determine their safety and efficacy [13].
Cognitive training (CT), which typically involves
guided practice on non-specific cognitive activities and
specific cognitive functions [14], is used worldwide [15].
There is substantial evidence on the use of CT for cogni-
tive impairment, but systematic reviews suggest that
current CT for PSCI still has limited effectiveness [16],
and patients cannot improve their cognitive function
quickly enough to return to daily life. Therefore, new
treatments or comprehensive therapeutic strategies
should be of utmost importance in future studies in
order to avoid the previously mentioned limitations [17].
Acupuncture is a complementary and alternative ther-
apy. It has a long history in the management of patients
with neurological symptoms [18], which has revealed
promising cost-effectiveness results [19]. Many studies
have highlighted the potential positive effects of acu-
puncture as a promising treatment for patients with
PSCI [20]. Promoting cholinergic neural transmission,
facilitating dopaminergic synaptic transmission, enhan-
cing neurotrophin signaling, suppressing oxidative stress,
and attenuating apoptosis are some of the proposed
mechanisms by which acupuncture improves cognitive
function [21]. However, the efficacy of acupuncture is
yet to be unequivocally defined. Since the acupoint se-
lection is heterogenous between studies, the conclusions
drawn are limited. Thus, the effect of appropriate acu-
points needs further research. Only two acupoints, Bai-
hui (DU20) and Shenting (DU24), will be used in this
therapeutic protocol, based on our previous study for
PSCI treatment [22, 23].
Currently, no single acupuncture intervention has
proved to be unequivocally beneficial for PSCI recovery
[20]. Systematic reviews have proposed that acupuncture
in combination with other therapies can improve cogni-
tive functions significantly [24]. Evidence also suggests
that CT combined with other interventions enhances
treatment benefits [14] since acupuncture focuses on
general cognitive function, while CT addresses one spe-
cific impaired cognitive aspect [25]. Their combination,
also considered a therapeutic regimen of TraditionalChinese Medicine (TCM) rehabilitation, may prove bet-
ter at improving cognitive function after stroke. This
protocol is sponsored by the 12th Five-year Plan project
of the Ministry of Science and Technology of the Peo-
ple’s Republic of China (grant number: 2013BAI10B01).
Further evidence and recommendations for clinical
practice supporting a therapeutic regimen of TCM re-
habilitation are currently insufficient. Although many
studies have addressed the potential use of acupuncture
to improve cognitive function, few have explored the ef-
fects of a therapeutic regimen of TCM rehabilitation in
patients with PSCI [26, 27]. Because of limitations in de-
sign or sample size, some of these studies provided
equivocal results, thus enhancing the need to conduct
high methodological quality trials with large samples
and longer follow-up periods. The purpose of this ran-
domized controlled trial is to test the cost-effectiveness
of TCM rehabilitation therapy and confirm its effective-
ness for PSCI treatment.
Methods/Design
Study design
The clinical study is a prospective, multicenter, large
sample, randomized controlled trial designed with
single-blinded assessments, which is being carried out in
seven inpatient and outpatient stroke rehabilitation
units. With prior written informed consent, a total of
416 eligible participants will be randomly allocated into
the intervention group or control group in a 1:1 ratio.
The control group will receive conventional treatment
and CT, while, the interventional group will receive con-
ventional treatment and a therapeutic regimen of TCM
rehabilitation (CT + acupuncture). A 12-week interven-
tion and 24-week follow-up period will be conducted for
this trial. The relative outcomes will be measured at
baseline, at the end of intervention (12 weeks), and after
the 24-week follow-up period (36 weeks). Fujian Univer-
sity of Traditional Chinese Medicine (FJTCM), as a
major undertaker of the study, is responsible for training
rehabilitation therapists on standard operation proced-
ure and supervising the progress of this trial in all clin-
ical sites. In addition, the randomization and blinding
will be performed by an independent statistician from
the Center of Evidence Based Medicine, FJTCM. A flow
diagram of this trial is presented in Fig. 1.
Participants and recruitment
The participants will be recruited from seven inpatient
and outpatient stroke rehabilitation units from FJTCM
Subsidiary Rehabilitation Hospital, Guangdong Province
Traditional Chinese Medical Hospital, The First Affili-
ated Hospital of Jinan University, Traditional Chinese
Medicine Hospital of Xinjiang Uygur Autonomous
Region, The Affiliated Huashan Hospital of Fudan
Fig. 1 CONSORT flow diagram of study design
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Medicine, and ShiyanTaihe Hospital, all in China. Our
study will be advertised on each hospital’s internet
homepages. Posters informing patients about this trial
are displayed in several community rehabilitation centers
and hospitals. Interested patients can contact the project
leader (PL) through their therapists, via phone, email, or
mail. After obtaining informed consent, the prospective
participants are screened according to the inclusion and
exclusion criteria. Those who comply with all criteria are
eligible to participate. The eligible individuals are invitedto participate in the trial and are directed to a diagnostic
assessment by a neurologist, followed by rehabilitation
assessments. Data on the design of the study is shown in
Table 1.
Inclusion criteria
This trial’s participants should meet all the following cri-
teria: (1) Signed informed consent by the patient or their
guardian to participate in this trial; (2) Present stroke
diagnosis according to the fourth national academic con-
ference on cerebrovascular disease’s Diagnostic Criteria
Table 1 Study design
Items Before intervention Intervention period Follow-up period




Inclusion and exclusion criteria ×
Randomization and allocation ×
Primary outcomes MMSE × × × ×





MBI × × ×




Treatment recorded × ×
Adverse events recorded × ×
Rehabilitation expenses questionnaire × × ×
aEvaluation in the week before intervention. bEvaluation in the week after intervention. cEvaluation in the week after follow-up. Abbreviations: MMSE, Mini-Mental
State Examination; MoCA, Montreal Cognitive Assessment; TAP, Test of attentional performance; WMS, Wechsler memory scale; TMT, Trail Making Test A and B;
Stroop, Stroop Test; MBI, Modified Barthel Index; SF-36, 36-Item Short Form Health Survey; FMA, Fugl-Meyer Motor Assessment; fMRI, Functional magnetic
resonance imaging; ERP, Event-related potentials
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firmed by computed tomography or magnetic resonance
imaging; (3) Mini-Mental Status Examination (MMSE)
score ≤24; (4) First ever stroke and within one year post-
stroke; (5) Aged between 45 to 75 years; and (6) Patient
should be conscious, with stable vital signs.
Exclusion criteria
Criteria for exclusion are as follows: (1) Patients who
suffer from brain tumor, brain trauma, brain parasite
disease, or other diseases that could cause cognitive im-
pairment; (2) Patients with severe language, vision, and/
or auditory impairment, or neuropsychiatric disorder
precluding cognitive examination; (3) Patients who suf-
fer from diseases related to cognitive impairment con-
firmed by anamnesis, doctors, or families, or with
history of cognitive drug use before stroke; (4) Beck De-
pression Scale score >13; (5) Patients with alcohol or
drug abuse; (6) Patients with severe illnesses, such as
heart, liver, kidney, and endocrine diseases, and
hematopoietic system disease; (7) Pregnant woman or
breastfeeding women; or (8) Patients who are included
in other clinical trials that would affect the evaluation
results of this study.Sample size
The sample size calculation is based on the improve-
ment of MMSE scores, which is used as the primary ef-
fect indicators to estimate. According to the similar
published articles [29], the mean difference in MMSE
scores before and after treatment is three points, with a
standard deviation of 1.5. According to our pilot study, a
therapeutic regimen of TCM rehabilitation (CT + acu-
puncture) can probably improve the MMSE by 3.52
points on average compared to the control group. Im-
provement will be measured according to the same size
of the estimation formula:





With a type I error of 5 % (α = 0.05) and 90 % power (β =
0.10), it is estimated that a sample size of 173 participants
per group will be required. Considering a 20 % dropout rate
during the study, a minimum of 416 total participants is
needed to reach the target 208 participants per group.
Randomization and allocation concealment
Stratified-block randomization would be applied into the
study, which will take each center as a stratification
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assigned to either the intervention group or control
group according to 1:1 equal proportion rule. The se-
quence of random allocation will be generated using the
PLAN sentences of the statistical software SAS 9.3 (SAS
institute Inc., Cary, NC, USA), by an independent statis-
tician who will not be involved in this trial from the
Center of Evidence Based Medicine, FJTCM. Also, the
sequence of random allocation will be concealed to out-
come assessors and the statistical analyst. Then, the eli-
gible participants will be informed of their allocation
result by the project manager via telephone after their
baseline information has been assessed, and the thera-
pists (including acupuncturist and cognitive therapists)
will be notified of the allocation and arrange the allo-
cated treatment directly for the patient.Blinding
In this trial, both the outcome assessors and the statis-
tical analyst will be blinded to the randomization alloca-
tion and will not be involved in performance of the
interventions. It will be, nevertheless, impossible to blind
the participants, acupuncturists, and cognitive therapists
since they will perform the interventional protocols. In
the meantime, a specified project manager will be
assigned to be in charge of the random allocated se-
quence and blind code of allocation, in which the inter-
vention group or control group will be replaced by the
letter A or B. Random parameters would be kept in the
blind codes, using sealed opaque envelopes to conceal
random allocation. Unblinding will only occur once all
the outcome data collection is completed at 36 weeks.Ethical issues
This protocol has been approved by the Ethics Committee
of FJTCM Subsidiary Rehabilitation Hospital (approval
number: 2013KY-005-01), Guangdong Province Trad-
itional Chinese Medical Hospital (approval number:
B2014-020-01), the First Affiliated Hospital of Jinan
university (approval number: (2014) Ethical review ap-
proval documents 25th), Traditional Chinese Medicine
Hospital of Xinjiang Uygur Autonomous Region (approval
number: 2013XE005), Affiliated Huashan Hospital of
Fudan University (approval number: (2014) Interim re-
view 262th), Zhongshan Hospital of Traditional Chin-
ese Medicine (approval number: 2014ZSZY-LLK-002),
and ShiyanTaihe Hospital (approval number: 2014001
Research review meeting 2nd). Each participating cen-
ter will receive approval from the local institutional re-
view board. Prior to study, signed informed consent
will be obtained from each participant. The names of
seven ethical bodies are listed in Additional File 1.Baseline tests
Descriptive data will be collected before randomization.
The descriptive data includes gender, age, height, weight,
nationality, education level, employment status, clinical
syndrome (left or right hemiplegia), and the type, fre-
quency, and location of the stroke at diagnosis. The Na-
tional Institute of Health Stroke Scale, an 11-item
evaluation tool to assess stroke severity, will be applied
at baseline to determine whether the two groups are
consistent before the intervention [30]. All subjects will
be assessed with the following measures: the severity of
cognitive impairment will be assessed using the Mini-
Mental Status Examination (MMSE), as well as the
Montreal Cognitive Assessment (MoCA); attention func-
tion will be measured with the Test of Attentional Per-
formance (TAP); memory function will be tested with
the Wechsler Memory Scale-Revised in Chinese (WMS-
RC); executive function will be evaluated with the Stroop
test, as well as the Trail Making Test; motor function
will be measured with the Fugl-Meyer Motor Assess-
ment Scores; activities of daily living (ADL) will be
assessed with the Modified Barthel Index (MBI); and
quality of life will be evaluated with the 36-Item Short
Form Health Survey (SF-36). Moreover, the functional
condition of the brain is examined by using a resting-
state functional magnetic resonance imaging (fMRI) and
event-related potentials (ERP).Intervention
The interventional group will receive a therapeutic regi-
men of TCM rehabilitation and conventional treatment,
while the control group will only receive CT and con-
ventional treatment. The conventional treatment con-
sists of health education, conventional medical therapy,
and routine rehabilitation training. The treatments will
be performed five times per week, over 12 weeks. For
quality management, all procedures performed by the
healthcare staff participating in this study will be stan-
dardized, including in the study protocol, treatment
methods, and assessments.Basic treatment
All participant will receive basic treatments following
the Chinese Medical Association’s Guidelines for the
Prevention and Treatment of Cerebrovascular Disease in
China (2007) [31] and Guidelines for Chinese stroke
rehabilitation [32]. Based on these guidelines and the
patient’s condition, the treating physician will manage
each case, including the use of drugs, stroke risk factor
prevention, and rehabilitation therapies, as well as post-
stroke comorbidity management including anticoagulant
therapy, blood pressure, anti-platelet aggregation, heart
disease, blood sugar, and lipid management.
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All the participants will receive an informational brochure
with basic knowledge on stroke, based on the Out of the
Misunderstanding of Stroke Patients’ Rehabilitation (the
bestseller books for health education after stroke from the
Chinese Association of TCM) [33]. In addition, a health
lecture is offered to participants in the hospitals, covering
various topics on stroke rehabilitation, including: the def-
inition of stroke; the type, prevention, etiology, and patho-
genesis of stroke; the concept of stroke rehabilitation; the
importance of early rehabilitation; best practices in stroke
rehabilitation; and nursing care.
Cognitive training
All the patients will receive CT based on the 2010 Na-
tional Stroke Foundation’s Clinical Guidelines for Stroke
Management [34]. The intervention group will receive
CT and acupuncture therapy simultaneously. The thera-
pists will tailor the treatment in accordance with each
patient’s assessment results, including different aspects
of CT (attention, memory, orientation, visual spatial
ability, execution, or calculation and so on). Further-
more, the level of difficulty will be based on patient’s
progress. The period of treatment will be sustainable for
12 weeks, at 30 minutes per day for five days a week.
Acupuncture therapy
The intervention group will be treated on two acupunc-
ture points (Baihui (DU20) and Shenting (DU24)). The
acupoint-location method is based on bone proportional
cun. Bone proportional cun is mainly marked as the pri-
mary landmarks by using joints on the surface of the
body; the length between the two joints will be dis-
counted for a certain amount of discretion in order to
determine the location of the acupoints. Baihui (DU20)
is located on the head, 5 B-cun superior to the anterior
hairline, on the anterior median line; or when the ears
are folded, Baihui (DU20) is located at the midpoint of
the connecting line between the auricular apices. Shent-
ing (DU24) is located on the head, 0.5 B-cun superior to
the anterior hairline, on the anterior median line.
Acupuncture will be performed by acupuncturists who
are TCM licensed, and have at least three years of ex-
perience. The acupuncture procedure starts with the pa-
tient in the sedentary or supine position. After acupoint
area sterilization, the acupuncturist’s left hand should fix
the skin of the stimulus area, and the right hand should
hold the disposable sterile acupuncture needle (Huatuo
brand, model 0.30 mm × 25 mm, Suzhou Medical Appli-
ance Factory, China). Then, the needle is inserted into
the acupoints subgaleally from the front to the rear
along the scalp, at an angle of 10 to 20 °, to a depth of
approximately 25 to 35 mm. Following insertion, stimu-
lation of the acupuncture point is applied until the de qisensation is achieved, which means that patients experi-
ence a certain feeling with a mixture of sourness, numb-
ness, distension, and pain from the acupuncture. The
acupuncturist will use the manipulation technique with
rapid twirling performed for two to three minutes every
10 minutes, at a frequency of 180 to 300 times/min.
Meanwhile, CT will be performed constantly for 30 mi-
nutes throughout the acupuncture therapy. Following
the treatment session, the needles will be withdrawn,
and a dry sterilized cotton ball will be slightly pressed
the holes of needles to avoid bleeding. The treatment
will be given once a day for five times a week, lasting for
12 continuous weeks.
Follow-up
After the 12-week treatment period, there is an out-
patient 24-week follow-up period. The medical staff will
follow up on the participants via telephone. Each partici-
pant is contacted once every four weeks, keeping record
of the medications and rehabilitation therapies. On the
final week of the follow-up period (24 weeks post-
intervention), participants will be referred for clinical
evaluation in order to assess their functional status, in-
cluding cognitive function, quality of life, and ADL.
Outcome measures
In this study, all the primary and secondary outcomes
measures will be tested at baseline (−2 to −1 week) and
after the intervention period (12 weeks). After follow-up
(36 weeks), the cognitive function, quality of life, and
ADL outcomes (MMSE, MoCA, SF-36, and MBI) will
also be evaluated. All outcome assessments will be inde-
pendently performed by experienced and blinded asses-
sors. A summary of all the measures in the trial is
shown in Table 1.
Primary outcomes
Mini-Mental State Examination
The Mini-Mental State Examination (MMSE), was first in-
troduced by Folstein et al. in 1975 [35], and we will use
the revised Chinese MMSE version [36]. It is a brief 30-
point questionnaire, divided into 10 items: time and place
orientation, short-term memory, attention and calculation,
recall, language skills, repetition, complex commands,
reading, writing, and copying of pentagons. When the
resulting MMSE is 24 points or less, this means that the
patient may suffer from some degree of cognitive impair-
ment. The total score of the individual items demonstrates
the recent severity of cognitive impairment.
Secondary outcomes
Montreal Cognitive Assessment
The Montreal Cognitive Assessment (MoCA) [37] is a 30-
point test that covers eight cognitive domains, including:
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attention, language, abstraction, delayed recall, and orien-
tation. Given the MMSE’s limitation in detecting early de-
mentia [38], the MoCA evaluates participants who suffer
from cognitive complaints. The revised Chinese MoCA
version will be used in this trial.
Test of Attentional Performance
The Test of Attentional Performance (TAP, Version 2.3)
[39], a computer-aided standard neuropsychological test,
is used to assess attention disorders. Four of its sub-tests
were chosen for this trial: alertness for reaction, general
anticipation (which belongs to general attention); Go/No
Go, and incompatibility for selective attention and di-
vided attention, which is essential in every attention as-
sessment. The TAP measures reaction time, and the
number of errors and omissions. The available TAP in
Chinese will be used in this study.
Wechsler Memory Scale-Revised in Chinese
Memory will be evaluated using the Wechsler Memory
Scale (WMS). The Wechsler Memory Scale-Revised in
Chinese (WMS-RC) will be used [40]. The test consists
of three sub-functions (11 sub-tests): long-term memory
(including information and orientation, forward recite
digit (1 to 100), backward recite digit (100 to 1), and ac-
cumulation), short-term memory (including visual rec-
ognition, picture recall, visual reproduction, associative
learning, touch, and comprehension memory), and im-
mediate memory (including digit span). The results of
the WMS-RC are expressed by memory quotient (MQ).
We will collect MQ values and all sub-test values for
analysis.
The Trail Making Test and the Stroop test
Executive function will be measured with the TMT and
the Stroop test. The TMT is one of the most popular
neuropsychological tests and provides information on
visual search and executive functions [41]. It consists of
part A and part B (TMT-A and TMT-B). In part A, the
participants are asked to make lines from 1 to 25, while
in part B, subjects should make lines from 1 to 25 while
alternating between circles and squares [42]. This study
also adopts the Color-Word Stroop interference test
using E-prime to assess subjects’ executive function.
Subjects were asked to judge if the color of the top row
in the computer screen corresponds to the color name
written at the bottom row, and press the left or the right
button, respectively [43].
Fugl-Meyer Motor Assessment
The Fugl-Meyer Motor Assessment evaluates upper and
lower limb motor functions systematically [44]. Themaximum score is 100, the upper extremity score is 66,
and the lower extremity score is 34 [45].Modified Barthel Index
ADL will be evaluated by the MBI [46]. The Barthel
Index was first introduced in 1965 and consists of 10
items: feeding, personal hygiene, dressing, bathing, toi-
leting, bowel control, bladder control, chair-bed transfer,
ambulation or wheelchair, and stair climbing [47]. The
BI was modified in 1989 to improve content reliability
and internal consistency, resulting in the MBI [48]. Each
item’s score ranges from 0 to a maximum that varies
from 5 to 15. The score indicates the ADL ability range
from inability to independence. Higher scores suggest
better functional and independent ADL abilities, thus a
score of 100 means total independence.36-Item Short Form Health Survey
Health-related quality of life is measured using the Chin-
ese version of the 36-item Short Form Health Survey
[49]. This questionnaire consists of 36 items related to
physical and mental health, which are grouped in eight
dimensions: physical functioning; role-physical, or the
limitation in daily role functioning due to physical prob-
lems; role-emotional, or the limitation in daily role func-
tioning due to emotional problems; bodily pain; general
health perception; vitality; social functioning; and mental
health perception, relating to physical and mental health
respectively [50].Functional Magnetic Resonance Imaging
Resting-state functional magnetic resonance imaging
(fMRI) will be used in this study to examine longitudinal
changes for cognitive impairment patients after stroke,
and to investigate the relationship between imaging
changes and cognitive recovery [51]. Subjects will be
scanned twice (before and after treatment), using a 3.0 T
signal MRI scanner (GE Healthcare, Little Chalfont, UK)
with a birdcage head coil [52].Event-related potentials
Cognitive function will be measured by event-related po-
tentials (ERPs). ERP P300 is related to cognitive function
closely, which can reflect information processing speeds,
attention, and the updating of working memory [53].
Reaction time and correctness rates (correctly pressing
the button for target and non-target stimulus presenta-
tions) will be measured to quantify the cognitive func-
tion, using the software system of Neuroscan ERPs
(SynAmps2 Model 8050, Compumedics USA, Ltd,
Charlotte, USA)
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Whenever an adverse event (AE) occurs during the
treatment or follow-up period, the medical staff will
manage it accordingly, while researchers will document
any AE in detail. Every participant will have the right to
report AEs at any given point in time during this trial,
and will receive appropriate medical attention. Serious
AEs will be immediately reported to the primary investi-
gator and the Human Research Ethics Committee of
FJTCM to determine whether the participant needs to
be withdrawn from the study.
Economic evaluation
Cost-effectiveness and incremental cost-effectiveness
(the required cost of improvement in cognitive function)
ratios, will be the primary economic outcomes in this
trial [54]. The cost of interventions comprises direct
costs and indirect costs. Any expenses involving rehabili-
tation treatments, rehabilitation assessment fees, auxil-
iary equipment, and other direct medical expenses
associated with stroke or direct non-medical cost
(including rehabilitation related transportation, special
diets, nurse escort fee, and other costs related directly to
the medical expenses) throughout the rehabilitation
period are classified as direct costs. In addition, the
number of workdays lost by participants during the
treatment and follow-up period will be used to evaluate
indirect costs. Incremental quality adjusted life years will
be the total of difference in duration of rehabilitation ef-
fects as weighted by cognitive function between inter-
vention group and control group during the treatment
and follow-up period.
Data collection and management
Firstly, screeners are responsible for the acquisition of
demographic and baseline characteristic data when the
participants are recruited. Outcome assessors play an
important role in evaluating the primary and secondary
outcomes at baseline, 12 weeks (end of intervention),
and 36 weeks (after the 24-week follow-up period). In
each center, after the source data has been added to the
case report form, two research assistants who are not
engaged in either treatment or evaluation will enter
those source data into an electronic data capture data-
base through the scientific research management plat-
form of FJTCM. Only the project manager has the right
to log into every center’s database. Moreover, a statistical
manager will be in charge of initial data organizing,
identifying, coding, and converting data to make sure
the format is proper for data analysis. Meanwhile, double
data entry will be used to promote data quality. All ma-
terials related to the participants’ privacy will be kept
confidential by the way of coding. Besides, all study doc-
uments will be retained securely for five years aftercompletion of the study, and the result of our study will
be published in open access journals.
Moreover, this trial has been monitored for safety con-
trol by an independent Data and Safety Monitoring
Board (DSMB), consisting of two senior therapists and
one rehabilitation physician who are experienced in
post-stroke cognitive impairment and have no direct in-
volvement in the study. The DSMB is an independent
board and is responsible for source data validation, and
AE management and reporting. For safety concerns, the
DSMB may have the right to recommend termination or
modification of the research, according to their clinical
judgment.
Statistical methods
All data will be analyzed using SAS version 8.2 (SAS
institute Inc., Cary, NC, USA) by an independent
blinded statistician. A statistical significance level of 0.05
will be used. For statistical description, continuous vari-
ables will be presented for each group using the mean ±
standard deviation for normal distribution, and median
and interquartile range for non-normal distribution. Cat-
egorical variables will be presented by using proportions
with their standard error. In order to compare the pri-
mary and secondary outcomes between groups, mea-
sured at baseline, post-intervention and post-follow-up,
the t-test or Mann–Whitney U test will be used for con-
tinuous variables and the Pearson chi-squared or Fisher’s
exact test will be used for categorical variables. Non-
parametric tests, Pearson chi-squared test, or Fisher’s
exact test will be used for expressing changes in effect
sizes of primary and secondary outcomes between
groups before and after treatment, and during the
follow-up period (at 12 weeks and 24 weeks).
To adjust the confounding influence if necessary, a
general linear model or linear regression will be applied
for dependent continuous variables, and a logistic re-
gression model for dependent categorical variables. The
analysis of the primary outcome will be expressed by
using full analysis set with the principle of intention-to
treat and the per-protocol set. The analysis of the sec-
ondary outcomes will be performed using the per-
protocol set. The analysis of AE will be undertaken by
using a chi-square test or Fisher’s exact test. Lastly, the
economic evaluation will be assessed using cost-
effectiveness analysis. Missing data will be imputed by
the last observation carried forward rules.
Discussion
Post-stroke cognitive impairment is highly prevalent all
over the world [16]. It significantly impairs patients’ par-
ticipation in rehabilitation, engagement in daily activ-
ities, and their quality of life [55]. Meanwhile, the high
economic burden that stroke rehabilitation imposes on
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therapies, mainly CT and pharmacological treatment,
lack sufficient evidence to support their effectiveness
due to the complexity of cognitive impairment manage-
ment [6]. The recent use of combined therapy has in-
creasingly attracted attention, offering a new prospect in
PSCI treatment [17].
Acupuncture is considered to be effective in improving
cognition and has the advantages of being simple, con-
venient, efficient, and inexpensive, without severe ad-
verse effects [20, 57]. A systematic review [58] has
proposed that acupuncture improves cognitive function
impairment in patients with PSCI, but the lack of high
quality research has prevented the development of
evidence-based recommendations for clinical practice.
This review also recommends that future clinical trials
should focus on the effect of acupuncture treatments
combined with a second treatment, aiming to find the
most cost-effective therapy combination that promotes
the greatest improvement in stroke rehabilitation.
Previous studies have been limited by random meth-
odology and small sample sizes [26, 27]. Thus, a pro-
spective, multicenter, large sample, single-blinded,
randomized controlled trial designed under strict sys-
tematic operational and high quality practices is needed
to evaluate whether a therapeutic regimen of TCM
rehabilitation leads to a more effective improvement in
PSCI.
A notable difference between our study and former
studies is that this trial will investigate, some domain-
specific cognitive functions as well as general cognitive
state. According to one article, patients with PSCI will
mainly exhibit dysfunctions in attention, memory, and
executive function [6]. To evaluate domain-specific cog-
nitive function various measures were selected: the TAP
to assess attention, the WMS-RC to evaluate memory,
and the TMT and Stroop test to measure executive func-
tion. In this study, detailed information on performance
in multifarious tasks designed for CT will be recorded,
allowing an insightful outcome analysis by taking into
account the severity of and inter-relationships among
the cognitive deficits in various domains. Besides, fMRI
and ERPs will be included in this trial as objective indi-
cators of cognitive function [59–61]. Since many stroke
patients who suffer from PSCI and movement disorders
cannot understand and/or perform tasks adequately,
resting-state fMRI was chosen over tasking-state fMRI
for this study [62]. Meanwhile, ERP P300 and resting-
state fMRI make it possible to provide a potential mech-
anism for the therapeutic effects of this trial’s approach,
and to further explore the relationship between cognitive
functional networks and brain structure, thus allowing
the researchers to investigate the relationship between
subjective scales and objective indicators.Adhere to the SPIRIT guidelines, a prospective, multi-
center, large sample, randomized controlled trial with
blinded assessments has been designed [63]. This proto-
col design has several strengths: (1) it is a multicenter
trial that will be carried out in seven inpatient and out-
patient stroke rehabilitation units, which enhances the
study’s external validity and sample representativeness;
(2) to guarantee quality, all staff in the study are re-
quired to complete training on standard operating pro-
cedures of the study protocol before recruiting; (3) this
study is centrally randomized to guarantee adequate
allocation concealment and blinded assessment of re-
sults [64]; (4) a 12-week intervention and 24-week
follow-up assessment can provide reliable long-term ef-
fect evidence for a therapeutic regimen of TCM rehabili-
tation treatment and its health economics in PSCI
clinical practice.
However, this protocol design also has potential limita-
tions: for example, it is not a double-blinded, placebo-
controlled trial. From the perspective of evidence-based
medicine, randomized, double-blind, placebo-controlled
trials are the best the trials that render the highest evi-
dence quality, but their feasibility is a major difficulty in
non-pharmacological research areas [65]. Considering
the ethics and participants’ adherence, blinding seems
difficult for acupuncture in a clinical study, thus ran-
domized, double-blinded, placebo-controlled trials may
be impossible. Considering these facts, this trial attempts
to reduce possible bias through blinding both outcome
assessors and data analyst. Further, potential spontan-
eous recovery at the early stage of stroke may have the
confounding effects on the trial.
To conclude, this trial aims to evaluate, under strictly
systemized operational and high quality practices,
whether a therapeutic regimen of TCM rehabilitation
can effectively improve cognitive functions recovery after
stroke under strict standard operational practices. If this
trial is successfully carried out and renders high quality
evidence to support a therapeutic regimen of TCM re-
habilitation for PSCI management, this low cost and
feasible therapy could be implemented on a larger scale
in clinical and community settings.
Trial status
Participant enrollment started in July 2014. The trial is
expected to be completed by the end of December 2016.
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